CRSP
Price
$40.72
Change
+$0.34 (+0.84%)
Updated
Dec 20 closing price
59 days until earnings call
KYMR
Price
$40.64
Change
+$1.50 (+3.83%)
Updated
Dec 20, 04:59 PM (EDT)
61 days until earnings call
Ad is loading...

CRSP vs KYMR

Header iconCRSP vs KYMR Comparison
Open Charts CRSP vs KYMRBanner chart's image
CRISPR Therapeutics AG
Price$40.72
Change+$0.34 (+0.84%)
Volume$3.35M
CapitalizationN/A
Kymera Therapeutics
Price$40.64
Change+$1.50 (+3.83%)
Volume$9.94K
CapitalizationN/A
CRSP vs KYMR Comparison Chart
Loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRSP vs. KYMR commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a Hold and KYMR is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (CRSP: $40.72 vs. KYMR: $40.64)
Brand notoriety: CRSP and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 176% vs. KYMR: 250%
Market capitalization -- CRSP: $3.48B vs. KYMR: $2.63B
CRSP [@Biotechnology] is valued at $3.48B. KYMR’s [@Biotechnology] market capitalization is $2.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, both CRSP and KYMR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 4 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 4 bullish, 6 bearish.
  • KYMR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CRSP and KYMR are a bad buy in the short-term.

Price Growth

CRSP (@Biotechnology) experienced а -6.99% price change this week, while KYMR (@Biotechnology) price change was -3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 18, 2025.

KYMR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.48B) has a higher market cap than KYMR($2.63B). KYMR YTD gains are higher at: 59.623 vs. CRSP (-34.952). KYMR has higher annual earnings (EBITDA): -160.96M vs. CRSP (-313.08M). CRSP has more cash in the bank: 1.94B vs. KYMR (550M). KYMR has less debt than CRSP: KYMR (88.2M) vs CRSP (228M). CRSP has higher revenues than KYMR: CRSP (200M) vs KYMR (87.6M).
CRSPKYMRCRSP / KYMR
Capitalization3.48B2.63B132%
EBITDA-313.08M-160.96M195%
Gain YTD-34.95259.623-59%
P/E RatioN/AN/A-
Revenue200M87.6M228%
Total Cash1.94B550M352%
Total Debt228M88.2M259%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
84
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRSPKYMR
RSI
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 3 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 5 days ago
81%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HMVTX17.910.22
+1.24%
Hartford MidCap Value R5
VPMCX161.181.62
+1.02%
Vanguard PRIMECAP Inv
DIECX37.860.01
+0.03%
BNY Mellon International Core Equity C
RREMX13.26N/A
N/A
RBC Emerging Markets Equity R6
EQIRX11.86-0.01
-0.10%
Allspring Emerging Markets Eq Inc R6

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+3.83%
CCCC - KYMR
61%
Loosely correlated
+2.60%
RXRX - KYMR
47%
Loosely correlated
-0.90%
CRSP - KYMR
45%
Loosely correlated
+0.83%
XENE - KYMR
45%
Loosely correlated
-0.54%
TRDA - KYMR
45%
Loosely correlated
+1.85%
More